首頁 > 市場調查報告書 > 製藥

呼吸器

全球支氣管擴張劑市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023至2030年預測

市場調查報告書

商品編碼

1306994

全球支氣管擴張劑市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023至2030年預測

Global Bronchodilators Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年05月01日 | 出版商:

Value Market Research | 英文 144 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球支氣管擴張劑市場需求預計將從2022年的238.7億美元成長到2030年的350.5億美元，2023-2030年的複合年成長率為4.92%。

支氣管擴張劑是一種藥物，有助於打開或擴張肺部氣道，使呼吸更順暢。它們通常用於治療哮喘、慢性阻塞性肺病（COPD）和其他導致呼吸困難的呼吸系統疾病。這些藥物通過放鬆肺部氣道周圍的肌肉發揮作用，從而使氣道變寬並改善氣流。

市場動態：

由於哮喘、慢性阻塞性肺病和支氣管炎等呼吸系統疾病的發病率不斷上升，支氣管擴張劑市場正經歷著顯著成長。隨著這些疾病的全球發病率不斷上升，對高效藥物的需求也在增加。人們對保持呼吸系統健康重要性的認知不斷提高是推動該市場發展的另一個因素。人們越來越意識到呼吸系統疾病的相關風險，並採取措施預防和控制這些疾病，其中包括使用支氣管擴張藥物。新型給藥技術的發展也推動了該市場的發展。計量吸入器、乾粉吸入器和霧化器等吸入裝置正變得越來越先進，使患者能夠更方便、更容易地使用這些藥物。全球老年人口不斷增加，推動了對支氣管擴張藥物的需求。老年人更易患呼吸系統疾病，通常需要長期使用支氣管擴張劑來控制症狀。製藥公司正投入巨資進行研發，以開發更有效的新藥。這推動了該領域的創新，並開發出新的有效治療方法。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清楚地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對支氣管擴張劑全球市場的各個細分市場進行了全面評估。支氣管擴張劑行業的成長和趨勢為本研究提供了整體方法。

市場細分：

支氣管擴張劑市場報告的這一部分提供了國家和地區層面細分市場的詳細數據，從而幫助戰略家確定各自產品或服務的目標人群以及即將到來的機會。

按藥物類別

BETA-腎上腺素能支氣管擴張劑
黃嘌呤衍生物
抗膽鹼能支氣管擴張劑

按給藥途徑

口服
鼻用（可吸入）
注射劑

按疾病分類

哮喘
慢性阻塞性肺病（COPD）
其他疾病

區域分析

本節涵蓋區域展望，重點介紹北美、歐洲、亞太、拉丁美洲、中東和非洲地區支氣管擴張劑市場的當前和未來需求。此外，報告還重點介紹了所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場中主要企業的綜合概況以及全球競爭格局的深入分析。支氣管擴張劑市場的主要參與者包括羅氏公司、葛蘭素史克公司、強生公司、阿斯利康公司、西門子醫療保健公司、雅培公司、Bio-Rad實驗室公司、賽默飛世爾科技公司、Quest Diagnostics公司、FOUNDATION MEDICINE公司、GSK公司、ASTRAZENECA公司、SIEMENS Healthcare GmbH公司、Abbott公司、Bio-Rad實驗室公司、Thermo Fisher Scientific公司、Quest Diagnostics公司、FOUNDATION MEDICINE, INC.本部分包括競爭格局的整體視圖，其中包括各種戰略發展，如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品上市和其他發展。

地區展望
產品介紹
北美銷售分析
- 概述、歷史和預測數據銷售分析
- 北美細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測數據銷售分析
- 歐洲銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測數據銷售分析
- 亞太地區細分市場銷售分析
- 亞太地區各國銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳大利亞銷售分析
- 亞太其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測數據銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測數據銷售分析
- 中東及非洲地區銷售分析
- 中東及非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第九章支氣管擴張劑企業競爭格局

支氣管擴張劑市場競爭
夥伴關係/合作/協議
合併與收購
新產品上市
其他發展

第10章: 公司簡介

公司佔有率分析
市場集中率
F. Hoffmann-La Roche Ltd
- 公司概況
- 公司收入
- 公司產品
- 近期發展
GSK plc.
- 公司概況
- 公司收入
- 產品
- 近期發展
Johnson & Johnson Services Inc.
- 公司概況
- 公司收入
- 產品
- 近期發展
AstraZeneca
- 公司概況
- 公司收入
- 產品
- 近期發展
Siemens Healthcare GmbH
- 公司概況
- 公司收入
- 產品
- 近期發展
Abbott
- 公司概況
- 公司收入
- 產品
- 近期發展
Bio-Rad Laboratories Inc.
- 公司概況
- 公司收入
- 產品
- 近期發展
Thermo Fisher Scientific
- 公司概況
- 公司收入
- 產品
- 近期發展
Quest Diagnostics Incorporated.
- 公司概況
- 公司收入
- 產品
- 近期發展
FOUNDATION MEDICINE INC.
- 公司概況
- 公司收入
- 產品
- 近期發展

注-在公司概況中，財務細節和近期發展視情況而定，如果是私營公司則可能不包括在內。

簡介目錄圖表

Product Code: VMR112111165

The global demand for Bronchodilator Market is presumed to reach the market size of nearly USD 35.05 BN by 2030 from USD 23.87 BN in 2022 with a CAGR of 4.92% under the study period 2023 - 2030.

A bronchodilator is a medication that helps to open up or dilate the air passages in the lungs, making it easier to breathe. They are typically used to treat asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders that cause difficulty breathing. These medicines work by relaxing the muscles that surround the airways in the lungs, which allows the air passages to widen and improve airflow.

Market Dynamics:

The bronchodilator market is experiencing significant growth due to the escalating prevalence of respiratory disorders like asthma, COPD, and bronchitis. With the global incidence of these conditions on the rise, the demand for efficient medications is also increasing. The growing awareness about the importance of maintaining good respiratory health is another factor driving this market. People are becoming more aware of the risks associated with respiratory disorders and are taking steps to prevent and manage these conditions, which includes the use of bronchodilator medications. The development of new drug delivery technologies is also driving the market. Inhalation devices such as metered-dose inhalers, dry powder inhalers, and nebulizers are becoming more advanced, making it more convenient and easy for patients to administer these medications. The global geriatric population is increasing, which is driving the demand for bronchodilator medications. The elderly are more susceptible to respiratory disorders and often require long-term treatment with bronchodilators to manage their symptoms. Pharmaceutical companies are investing heavily in research and development to develop new and more effective medications. This is driving innovation in the field and leading to the development of new effective treatments.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of bronchodilator. The growth and trends of bronchodilator industry provide a holistic approach to this study.

Market Segmentation:

This section of the bronchodilator market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Class

Beta-Adrenergic Bronchodilators
Xanthine Derivatives
Anticholinergic Bronchodilators

By Route Of Administration

Oral
Nasal (Inhalable)
Injectable

By Disease

Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Bronchodilator market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the bronchodilator market include F. Hoffmann-La Roche Ltd, GSK plc., Johnson & Johnson Services, Inc., AstraZeneca, Siemens Healthcare GmbH, Abbott, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Quest Diagnostics Incorporated., FOUNDATION MEDICINE, INC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . BRONCHODILATOR - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Drug Class
- 3.7.2 Market Attractiveness Analysis By Route Of Administration
- 3.7.3 Market Attractiveness Analysis By Disease
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL BRONCHODILATOR MARKET ANALYSIS BY DRUG CLASS

5.1 Overview by Drug Class
5.2 Historical and Forecast Data
5.3 Analysis by Drug Class
5.4 Beta-Adrenergic Bronchodilators Historic and Forecast Sales by Regions
5.5 Xanthine Derivatives Historic and Forecast Sales by Regions
5.6 Anticholinergic Bronchodilators Historic and Forecast Sales by Regions

6 . GLOBAL BRONCHODILATOR MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

6.1 Overview by Route Of Administration
6.2 Historical and Forecast Data
6.3 Analysis by Route Of Administration
6.4 Oral Historic and Forecast Sales by Regions
6.5 Nasal (Inhalable) Historic and Forecast Sales by Regions
6.6 Injectable Historic and Forecast Sales by Regions

7 . GLOBAL BRONCHODILATOR MARKET ANALYSIS BY DISEASE

7.1 Overview by Disease
7.2 Historical and Forecast Data
7.3 Analysis by Disease
7.4 Asthma Historic and Forecast Sales by Regions
7.5 Chronic Obstructive Pulmonary Disease (COPD) Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL BRONCHODILATOR MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE BRONCHODILATOR COMPANIES

9.1. Bronchodilator Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF BRONCHODILATOR INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. F. Hoffmann-La Roche Ltd
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. GSK plc.
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Johnson & Johnson Services Inc.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. AstraZeneca
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Siemens Healthcare GmbH
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Abbott
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Bio-Rad Laboratories Inc.
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Thermo Fisher Scientific
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Quest Diagnostics Incorporated.
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. FOUNDATION MEDICINE INC.
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments